View in EDS HTML Full Text PDF Full Text

Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11.

Saved in:
Bibliographic Details
Title: Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11.
Authors: Bertuccioli A; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.; Microbiota International Clinical Society, Torino, Italy., Sisti D; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy., Lazzerini N; USL Tuscany South-East Company, Valdarno Hospital 'La Gruccia', U.O.S.D. Digestive Endoscopy, Interventional and Emergency Unit, Montevarchi, Italy., Palazzi CM; Microbiota International Clinical Society, Torino, Italy., Zonzini GB; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.; Microbiota International Clinical Society, Torino, Italy., Ragazzini M; Microbiota International Clinical Society, Torino, Italy., Belli A; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.
Source: Frontiers in medicine [Front Med (Lausanne)] 2025 May 20; Vol. 12, pp. 1604319. Date of Electronic Publication: 2025 May 20 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40463977
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bertuccioli+A%22">Bertuccioli A</searchLink>; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.; Microbiota International Clinical Society, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Sisti+D%22">Sisti D</searchLink>; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.<br /><searchLink fieldCode="AU" term="%22Lazzerini+N%22">Lazzerini N</searchLink>; USL Tuscany South-East Company, Valdarno Hospital 'La Gruccia', U.O.S.D. Digestive Endoscopy, Interventional and Emergency Unit, Montevarchi, Italy.<br /><searchLink fieldCode="AU" term="%22Palazzi+CM%22">Palazzi CM</searchLink>; Microbiota International Clinical Society, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Zonzini+GB%22">Zonzini GB</searchLink>; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.; Microbiota International Clinical Society, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Ragazzini+M%22">Ragazzini M</searchLink>; Microbiota International Clinical Society, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Belli+A%22">Belli A</searchLink>; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101648047%22">Frontiers in medicine</searchLink> [Front Med (Lausanne)] 2025 May 20; Vol. 12, pp. 1604319. <i>Date of Electronic Publication: </i>2025 May 20 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101648047 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-858X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222296858X%22">2296858X </searchLink><i>NLM ISO Abbreviation: </i>Front Med (Lausanne) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40463977
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fmed.2025.1604319
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1604319
    Titles:
      – TitleFull: Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bertuccioli A
      – PersonEntity:
          Name:
            NameFull: Sisti D
      – PersonEntity:
          Name:
            NameFull: Lazzerini N
      – PersonEntity:
          Name:
            NameFull: Palazzi CM
      – PersonEntity:
          Name:
            NameFull: Zonzini GB
      – PersonEntity:
          Name:
            NameFull: Ragazzini M
      – PersonEntity:
          Name:
            NameFull: Belli A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 05
              Text: 2025 May 20
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2296-858X
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in medicine
              Type: main
ResultId 1